BR100 Increased By (0.67%)
BR30 Increased By (0.87%)
KSE100 Increased By (0.52%)
KSE30 Increased By (0.56%)
BECO 6.06 Increased By ▲ 0.29 (5.03%)
BML 53.10 Increased By ▲ 0.10 (0.19%)
BOP 34.33 Increased By ▲ 0.34 (1%)
CNERGY 8.18 Increased By ▲ 0.07 (0.86%)
DCL 12.46 Increased By ▲ 0.26 (2.13%)
FCCL 53.25 Increased By ▲ 0.42 (0.8%)
FCSC 5.22 Increased By ▲ 0.15 (2.96%)
FFL 18.09 Increased By ▲ 0.14 (0.78%)
FNEL 1.30 Increased By ▲ 0.01 (0.78%)
HUMNL 10.90 Increased By ▲ 0.02 (0.18%)
KEL 8.06 Increased By ▲ 0.04 (0.5%)
KOSM 5.49 Decreased By ▼ -0.03 (-0.54%)
MLCF 87.47 Increased By ▲ 0.96 (1.11%)
NBP 186.50 Increased By ▲ 1.34 (0.72%)
PACE 10.78 Increased By ▲ 0.20 (1.89%)
PAEL 39.60 Increased By ▲ 0.18 (0.46%)
PIAHCLA 26.14 Decreased By ▼ -0.08 (-0.31%)
PIBTL 16.88 Increased By ▲ 0.21 (1.26%)
PPL 229.69 Increased By ▲ 1.51 (0.66%)
PRL 34.76 Increased By ▲ 0.08 (0.23%)
PTC 67.20 Increased By ▲ 1.87 (2.86%)
SEARL 90.88 Increased By ▲ 0.75 (0.83%)
SSGC 26.83 Increased By ▲ 0.23 (0.86%)
TELE 8.71 Increased By ▲ 0.43 (5.19%)
THCCL 59.20 Increased By ▲ 0.70 (1.2%)
TPLP 8.45 Increased By ▲ 0.23 (2.8%)
TREET 24.74 Increased By ▲ 0.21 (0.86%)
TRG 70.06 Increased By ▲ 0.35 (0.5%)
WAVES 10.04 Increased By ▲ 0.10 (1.01%)
WTL 1.28 No Change ▼ 0.00 (0%)
Topic

Pfizer shot

Singapore sees early rush for Sinovac vaccine

Singapore sees early rush for Sinovac vaccine

Updated 19 Jun, 2021 07:21pm
  • Singapore has vaccinated almost half its 5.7 million population with at least one dose of the vaccines from Pfizer-BioNTech and Moderna. Both have shown efficacy rates of well over 90% against symptomatic disease in clinical trials, compared with Sinovac's 51%.
Vietnam approves Pfizer/BioNTech COVID-19 vaccine for emergency use

Vietnam approves Pfizer/BioNTech COVID-19 vaccine for emergency use

Published 12 Jun, 2021 08:46pm
  • Vietnam is trying to accelerate its vaccine procurement drive to tackle a more stubborn wave of infections, even though its overall case load and fatality numbers remain relatively low.
  • Vietnam, with a population of around 98 million, has recorded a total of 10,241 coronavirus cases, with 58 deaths, since the pandemic began. Its domestic inoculation started in March.
India scraps local trials for COVID shots, says Pfizer vaccine could arrive by July

India scraps local trials for COVID shots, says Pfizer vaccine could arrive by July

Published 27 May, 2021 06:55pm
  • The world's second-most populous country this month recorded its highest monthly COVID-19 death toll since the pandemic began last year, accounting for just over a third of the overall total.
  • India reported 211,298 new infections on Thursday, the world's highest daily rise, but nearly half the daily infections it recorded earlier this month.
Sri Lanka approves Pfizer COVID vaccine for emergency use

Sri Lanka approves Pfizer COVID vaccine for emergency use

Published 08 May, 2021 04:17pm
  • Dr. Sudharshani Fernandopulle, the minister overseeing the fight against the epidemic, said in a statement the government would order 5 million doses of the Pfizer vaccine.
  • Sri Lanka is the first country in South Asia to approve the Pfizer vaccine. It has also approved Russia's Sputnik and China's Sinopharm vaccines for emergency use.
Brazil to receive 1 million Pfizer vaccine doses on Thursday

Brazil to receive 1 million Pfizer vaccine doses on Thursday

Published 28 Apr, 2021 08:22pm
  • Over the weekend, the health ministry announced that 30% fewer vaccines had been received between January and April than expected. Queiroga said the Covax facility, an international cooperation to assist countries secure vaccines, had moved up the expected delivery of 2 million doses to May.
South Korea signs with Pfizer for additional 40mn COVID-19 vaccine doses

South Korea signs with Pfizer for additional 40mn COVID-19 vaccine doses

Published 24 Apr, 2021 05:58pm
  • It added that it had secured a total 192 million doses of vaccines, including those from Moderna Inc, AstraZeneca PLC, Johnson & Johnson's and Novavax.
  • "The government has acquired COVID-19 vaccines large enough to vaccinate approximately 100 million people...(which) is double the entire population of South Korea," Health Minister Kwon Deok-cheol told a briefing.
EU's von der Leyen says EU to receive 50mn more Pfizer shots in Q2

EU's von der Leyen says EU to receive 50mn more Pfizer shots in Q2

Published 14 Apr, 2021 05:32pm
  • Ursula von der Leyen said the earlier deliveries, which will start this month, will take total supplies to the EU from Pfizer to 250 million doses in the second quarter of this year.
  • She also confirmed the Commission was in talks with the two companies for a new contract for 1.8 billion doses to be delivered in 2022 and 2023, confirming a Reuters report last week.
Pfizer to pursue bringing COVID-19 vaccine to India after import relaxation

Pfizer to pursue bringing COVID-19 vaccine to India after import relaxation

Published 13 Apr, 2021 08:27pm
  • "We have noted the recent announcement with regard to the regulatory pathway for global vaccines," a Pfizer spokesperson told Reuters in an email.
  • "We remain committed to continuing our engagement with the government towards making the Pfizer and BioNTech vaccine available for use in the government's immunisation program."
South Africa signs deal for 20mn Pfizer COVID-19 doses

South Africa signs deal for 20mn Pfizer COVID-19 doses

Updated 06 Apr, 2021 07:29pm
  • The deal is another fillip for the country worst hit by COVID-19 infections in Africa as it adds to the 31 million single-shot doses from Johnson & Johnson which the government approved on Thursday.
  • The country has also been allocated 12 million shots under the World Health Organization's COVAX scheme and is likely to get doses for 10 million people from the African Union's AVATT initiative.
UK data show good immune response in over 80s after 2-dose Pfizer COVID-19 shot

UK data show good immune response in over 80s after 2-dose Pfizer COVID-19 shot

Published 01 Apr, 2021 05:32pm
  • "We were surprised, and very pleased," Moss told reporters at a briefing about the findings. "But, of course, this does go with the excellent clinical protection that we're seeing with the vaccine - so it does correlate."
  • Pfizer and its co-developer BioNTech said earlier on Thursday that updated clinical trial data showed their vaccine is around 91% effective at preventing COVID-19 cases.
Europe to get 4mn more Pfizer/BioNTech COVID-19 shots this month

Europe to get 4mn more Pfizer/BioNTech COVID-19 shots this month

Updated 10 Mar, 2021 07:24pm
  • The doses to vaccinate two million people will be supplied in addition to the planned deliveries, to ease border movement and to tackle virus hotspots, the Commission said.
  • "To tackle aggressive variants of the virus and to improve the situation in hotspots, quick and decisive action is necessary," the president of the Commission, Ursula von der Leyen, said.
Brazil to get extra 5mn COVID-19 doses from Pfizer

Brazil to get extra 5mn COVID-19 doses from Pfizer

Updated 08 Mar, 2021 10:16pm
  • Speaking in Brasilia, Guedes said President Jair Bolsonaro had spoken with the global head of Pfizer and was scheduled to speak with the head of Janssen, the pharmaceutical subsidiary of Johnson & Johnson.
  • The government last week said it intended to buy 100 million doses from Pfizer and 38 million from Janssen through the end of December.
Brazil approves Pfizer's COVID-19 shot, but has none to use

Brazil approves Pfizer's COVID-19 shot, but has none to use

Published 23 Feb, 2021 07:44pm
  • The Pfizer/BioNTech shot is the first vaccine against the novel coronavirus to receive full approval in Brazil, Anvisa said. Other vaccines developed by AstraZeneca and China's Sinovac Biotech Ltd, have only been approved for emergency use so far.
  • The approval is good news for a country whose immunization campaign has been plagued by delays and political squabbling.
'Real-world' UK data shows 70pc decline in COVID infections after first Pfizer shot

'Real-world' UK data shows 70pc decline in COVID infections after first Pfizer shot

Published 22 Feb, 2021 09:27pm
  • "Overall, we're seeing a really strong effect to reducing any infection, asymptomatic and symptomatic," PHE's strategic response director Susan Hopkins told a media briefing.
  • "Hospitalisation and deaths rates are falling in all age groups, but the oldest age groups are seeing the fastest decline since the peak in mid-January," a PHE statement said.
Loading...